| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Chief Operating Officer | Stock Option (Right to Buy) | 0 | $952K | $36.05 | Jul 17, 2025 | Direct |
| Blueprint Medicines Corp | Chief Operating Officer | Common Stock | 0 | $0 | $101.84 | Jul 17, 2025 | Direct |
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 31K | Jun 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | Jul 17, 2025 | 11 | $0 | 4 | Jul 21, 2025 | Chief Operating Officer |
| BPMC | Blueprint Medicines Corp | Jul 3, 2025 | 1 | -$150K | 4 | Jul 8, 2025 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Jun 11, 2025 | 1 | $0 | 4 | Jun 12, 2025 | Director |
| BPMC | Blueprint Medicines Corp | May 19, 2025 | 3 | -$229K | 4 | May 21, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | May 5, 2025 | 4 | -$231K | 4 | May 7, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Mar 24, 2025 | 1 | -$216K | 4 | Mar 26, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Mar 5, 2025 | 1 | -$577K | 4 | Mar 7, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Mar 1, 2025 | 2 | $0 | 4 | Mar 4, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Feb 20, 2025 | 1 | -$216K | 4 | Feb 24, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Jan 21, 2025 | 4 | -$250K | 4 | Jan 23, 2025 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Dec 18, 2024 | 2 | -$218K | 4 | Dec 20, 2024 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Nov 27, 2024 | 1 | -$216K | 4 | Dec 2, 2024 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Jul 1, 2024 | 1 | $0 | 4 | Jul 8, 2024 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| BPMC | Blueprint Medicines Corp | Mar 7, 2024 | 1 | -$550K | 4 | Mar 11, 2024 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Mar 1, 2024 | 2 | $0 | 4 | Mar 6, 2024 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| BPMC | Blueprint Medicines Corp | Mar 6, 2023 | 2 | -$140K | 4 | Mar 8, 2023 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | CHIEF OPERATING OFFICER |
| BPMC | Blueprint Medicines Corp | Nov 3, 2022 | 1 | -$24.1K | 4 | Nov 7, 2022 | CHIEF OPERATING OFFICER |
| XLO | Xilio Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| BPMC | Blueprint Medicines Corp | Mar 3, 2022 | 2 | -$131K | 4 | Mar 8, 2022 | CHIEF COMMERCIAL OFFICER |
| BPMC | Blueprint Medicines Corp | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | CHIEF COMMERCIAL OFFICER |
| BPMC | Blueprint Medicines Corp | Nov 3, 2021 | 1 | -$56.6K | 4 | Mar 23, 2022 | CHIEF COMMERCIAL OFFICER |
| XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | Director |